Aripiprazole Bromobutoxyquinoline Impurity

N° de SZ CAT:	SZ-A001012
Número CAS	129722-34-5
Mol.F.	C13H16BrNO2
Peso Molecular	298.2
Status de Fatura	In Stock

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

Nome Químico: 7-(4-Bromobutoxy)-3,4-dihydroquinolin-2-one,

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

Sorrisos: BrCCCCOC1=CC2=C(C=C1)CCC(N2)=O

Formulation of aripiprazole-loaded pH-modulated solid dispersions via hot-melt extrusion technology: In vitro and In vivo studies
Haley McFall1 , Sandeep Sarabu1 , Vijaykumar Shankar1 , Suresh Bandari1 , S. Narasimha Murthy1 , Karl Kolter2 , Nigel Langley3 , Dong Wuk Kim4**, Michael A. Repka
International Journal of Pharmaceutics Volume 554, 10 January 2019, Pages 302-311

Molecular determinants of the intrinsic efficacy of the antipsychotic aripiprazole
Carmen Klein Herenbrink, Ravi Verma, Herman D Lim, Anitha Kopinathan, Alastair Keen, Jeremy Shonberg, Christopher J. Draper-Joyce, Peter J. Scammells, Arthur Christopoulos, Jonathan A Javitch, Ben Capuano, Lei Shi, and J Robert Lane
ACS Chem. Biol. 2019, 14, 8, 1780–1792

Identification of Degradation Impurities in Aripiprazole Oral Solution Using LC-MS and Development of Validated Stability Indicating Method for Assay and Content of Two Preservatives by RP-HPLC
M. V. V. N. Murali Krishna, Sumathi V. Rao & N. V. S. Venugopal
European Journal of Chemistry 2010, 1(1), 20-27

Development of stability indicating, validated HPLC method for quantitative determination of Aripiprazole and its impurities
Nandini R. Pai*, Deepnandan S. Dubhashi
Der Pharmacia Lettre, 2010, 2(4): 1-10

Aripiprazole Bromobutoxyquinoline Impurity is chemically 7-(4-Bromobutoxy)-3,4-dihydroquinolin-2-one, . Aripiprazole Bromobutoxyquinoline Impurity is supplied with detailed characterization data compliant with regulatory guideline. Aripiprazole Bromobutoxyquinoline Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Aripiprazole.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

products.relatedproducts

3-Chloro-N-(4-methoxyphenyl)propanamide

N° de SZ CAT:	: SZ-A001050
Número CAS	: 19313-87-2
Mol.F.	: C10H12ClNO2
Peso Molecular	: 213.7
Status de Fatura	: Custom Synthesis

5-(4-Bromobutoxy)-3,4-dihydroquinolin-2(1H)-one

N° de SZ CAT:	: SZ-A001031
Número CAS	: 63309-35-3
Mol.F.	: C13H16BrNO2
Peso Molecular	: 298.2
Status de Fatura	: Custom Synthesis

Aripiprazole

N° de SZ CAT:	: SZ-A001001
Número CAS	: 129722-12-9
Mol.F.	: C23H27Cl2N3O2
Peso Molecular	: 448.4
Status de Fatura	: In Stock

Aripiprazole 3,4-Dichloro Impurity

N° de SZ CAT:	: SZ-A001015
Número CAS	: 203395-75-9
Mol.F.	: C23H27Cl2N3O2
Peso Molecular	: 448.4
Status de Fatura	: In Stock

Aripiprazole 3,4-Dichlorophenyl Piperazine Impurity

N° de SZ CAT:	: SZ-A001016
Número CAS	: 57260-67-0
Mol.F.	: C10H12Cl2N2
Peso Molecular	: 231.1
Status de Fatura	: Custom Synthesis
Rel. CAS No	: 88138-89-0 (HCl salt) ; 110407-25-5 (HBr salt) ; 876132-14-8 (Oxalate salt)